Why It Matters
Alabama patients facing potential cancer diagnoses will no longer be required to pay out-of-pocket costs for follow-up screening tests after routine mammograms or prostate exams detect abnormalities. Two new state laws close a coverage gap that health advocates say has long delayed early detection — particularly for lower-income residents — by shifting the financial burden of secondary screenings onto health insurers.
Early cancer detection is widely linked to improved survival rates and lower long-term treatment costs. For many Alabama patients, the prospect of paying hundreds of dollars for supplemental tests after a routine screening had served as a financial deterrent to pursuing timely follow-up care.
What Happened
Alabama Governor Kay Ivey signed House Bill 300 into law earlier this month, requiring health insurers operating in the state to cover or reimburse the cost of breast cancer screenings and any subsequent diagnostic testing when an abnormality is identified. A companion measure addressing prostate cancer screenings was enacted alongside it.
The legislation was sponsored by Rep. Frances Holk-Jones, R-Foley, who was diagnosed with Stage 2 breast cancer in October 2025 after a secondary screening — the type of follow-up test the new law now requires insurers to cover. Holk-Jones’s cancer was detected following a routine mammogram that showed an abnormality, leading to additional diagnostic tests, a lumpectomy, and a course of radiation treatment.
Under existing insurance rules, routine screenings such as mammograms and MRIs were already covered. However, when those screenings flagged irregularities, the cost of further diagnostic procedures — such as ultrasounds or biopsies — fell to patients in many cases.
Holk-Jones said in an interview that the cumulative costs of multiple follow-up tests add up rapidly before a patient even reaches a surgical procedure. “You’re quickly into $500, if not $1,000 along the way before you even have the surgery itself,” she said.
By the Numbers
- A January 2025 study by the American Cancer Society Cancer Action Network (ACS CAN) found that patients can face approximately $170 in out-of-pocket costs for secondary testing after a routine mammogram detects an abnormality.
- Holk-Jones estimated that pre-surgical diagnostic costs could reach $500 to $1,000 for patients going through multiple rounds of follow-up testing prior to a lumpectomy or mastectomy.
- Holk-Jones underwent five rounds of radiation as part of her treatment — a course she attributed to early-stage detection made possible by secondary screening.
- The two laws — covering breast and prostate cancer screenings — represent a dual expansion of mandatory insurance coverage for supplemental cancer diagnostics in Alabama.
- HB 300 was signed into law in March 2026, with coverage requirements taking effect for insurance policies renewed or issued after the law’s enactment.
Zoom Out
Alabama joins a growing number of states that have moved to eliminate cost-sharing requirements for supplemental cancer screenings following federal guidance and advocacy from oncology and patient rights organizations. The Affordable Care Act already required insurers to cover preventive screenings without cost-sharing, but follow-up diagnostic tests triggered by abnormal results have historically occupied a regulatory gray area that left patients financially exposed.
Jane Adams, government relations director for ACS CAN in Alabama, noted that cost remains a persistent barrier to follow-up care. “When you’re low income, every dollar counts,” she said in a statement to reporters, emphasizing that the financial hurdle of secondary testing can prevent timely diagnoses in populations that already face disproportionate cancer mortality rates.
Several other states, including Illinois and New York, have enacted similar measures targeting supplemental screening coverage gaps in recent years, reflecting broader national momentum toward eliminating financial barriers to diagnostic care after abnormal screening results.
What’s Next
With both laws now signed, Alabama’s Department of Insurance is expected to issue guidance to health insurers operating in the state outlining compliance requirements and reimbursement protocols. Insurers will need to update their benefit structures and policyholder communications to reflect the new coverage mandates.
Health advocates plan to monitor implementation to ensure that patients receive coverage without excessive administrative barriers such as prior authorization requirements. Holk-Jones has indicated she intends to remain engaged on cancer screening access issues during future legislative sessions, potentially expanding the scope of coverage requirements for other diagnostic procedures.